Absci (ABSI) Total Debt (2020 - 2025)
Absci (ABSI) posted Total Debt of $12.8 million for Q3 2025, down 0.74% sequentially from $12.9 million in Q2 2025, and up 494.66% YoY from $2.2 million in Q3 2024.
Absci (ABSI) Total Debt (2020 - 2025) Analysis & Trends
Absci has reported Total Debt for 6 years, with the latest figure at $12.8 million in Q3 2025.
- Quarterly Total Debt rose 494.66% year-over-year to $12.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $12.8 million (up 494.66% YoY) and the FY2024 annual result came in at $14.0 million, down 19.55% from the prior year.
- Total Debt fell to $12.8 million in Q3 2025 per ABSI's latest filing, from $12.9 million in the prior quarter.
- Over five years, Total Debt peaked at $17.4 million in Q4 2023 and troughed at $531000.0 in Q1 2022.
- A 5-year average of $7.1 million and a median of $6.4 million in 2022 frame the typical range for Total Debt.
- The sharpest annual moves came in 2021 and 2023: Total Debt slumped 76.45% in 2021, then soared 1254.05% in 2023.
- Over 5 years, Total Debt stood at $1.1 million in 2021, then surged by 610.32% to $8.0 million in 2022, then surged by 118.06% to $17.4 million in 2023, then fell by 19.55% to $14.0 million in 2024, then decreased by 8.51% to $12.8 million in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $12.8 million, $12.9 million, and $13.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 12.82 Mn |
| Jun 30, 2025 | 12.91 Mn |
| Mar 31, 2025 | 13.43 Mn |
| Dec 31, 2024 | 14.01 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 3.75 Mn |
| Dec 31, 2023 | 17.41 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 6.38 Mn |
| Mar 31, 2023 | 7.19 Mn |
| Dec 31, 2022 | 7.98 Mn |
| Sep 30, 2022 | 6.52 Mn |
| Jun 30, 2022 | 7.13 Mn |
| Mar 31, 2022 | 531,000.00 |
| Dec 31, 2021 | 1.12 Mn |
| Sep 30, 2021 | 1.71 Mn |
| Jun 30, 2021 | 3.35 Mn |
| Dec 31, 2020 | 4.77 Mn |